status quo of quo vadis? - KCE
status quo of quo vadis? - KCE
status quo of quo vadis? - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>KCE</strong> Reports 76 Quality development in general practice in Belgium: <strong>status</strong> <strong>quo</strong> or <strong>quo</strong> <strong>vadis</strong> ? 57<br />
Ten key issues can be identified for developing the framework. All stakeholders need to<br />
be involved in the development and the validation process <strong>of</strong> this framework in order to<br />
achieve success. The German and UK examples learn that legislation coupled with<br />
specific financial incentives is a powerful stimulus.<br />
4.3.1 Need for pr<strong>of</strong>essional culture change<br />
The GPs should continuously bear in mind the importance <strong>of</strong> quality improvement<br />
principles when performing their daily work. GPs should become familiar with the<br />
concepts <strong>of</strong> quality development, measurement <strong>of</strong> indicators and the use <strong>of</strong> the quality<br />
cycle.<br />
The involvement <strong>of</strong> GP opinion leaders and scientific bodies is the most critical<br />
precondition to succeed in quality development initiatives at the individual, practice,<br />
regional and national levels. Australia is the most outstanding example <strong>of</strong> the power <strong>of</strong><br />
the pr<strong>of</strong>ession to launch effective quality programs. Opinion leaders <strong>of</strong> general practice<br />
in the UK, Australia and the Netherlands closely interact with the academics. The GP<br />
opinion and scientific leaders in these countries outlined the concepts <strong>of</strong> the quality<br />
development programmes and subsequently marketed these to the pr<strong>of</strong>essional bodies.<br />
In Belgium, academic departments and scientific bodies also have to take up their<br />
position in the quality debate. They must define the content <strong>of</strong> the quality initiatives and<br />
how the pr<strong>of</strong>ession will achieve their successful implementation.<br />
4.3.2 Health Authorities in a future quality system<br />
The role <strong>of</strong> the Health Authorities is first to address a quality policy that deals with<br />
priority aspects and anticipates the different steps from data collection to the use <strong>of</strong><br />
results for further improvement. Authorities must also define the tools that should be<br />
promoted for quality improvement in general practice. The choice <strong>of</strong> the most<br />
appropriate tools must adhere to the scientific literature and experience from other<br />
countries, as described in this report.<br />
A very powerful drive for change is a legal framework that introduces the requirements<br />
for quality development. The UK and Dutch pr<strong>of</strong>essional bodies have referred to<br />
implicit thread <strong>of</strong> formal regulations on quality. The UK and Australia are successful<br />
illustrations <strong>of</strong> the need for a pre-existing legal framework. The consequences <strong>of</strong><br />
registration <strong>of</strong> data for quality measurement will be clearly determined beforehand.<br />
Political will and leadership are needed to put the development <strong>of</strong> quality in general<br />
practice on the political agenda, including the specification <strong>of</strong> a time frame in which<br />
general practice should adhere to a quality development scheme.<br />
Furthermore the Authorities have a facilitating role:<br />
• To support a platform that will collect the data and to create an independent<br />
trustworthy body that will provide feedbacks to the GPs and stakeholders;<br />
• To promote and financially support standardised IT equipment that allows the<br />
collection <strong>of</strong> routine data for the measurement <strong>of</strong> quality indicators.<br />
4.3.3 Stakeholders<br />
All countries that have adopted successful quality development strategies have a finely<br />
tuned interaction between the key groups influencing the choice <strong>of</strong> quality measures i.e.<br />
purchasers, patients and physicians. 17 For Belgium the following stakeholders could take<br />
part in quality development i.e., general practitioners, scientific GP bodies, regional<br />
organisations <strong>of</strong> general practice, academic departments <strong>of</strong> general practice, other<br />
organisations <strong>of</strong> primary health care like nursing and regional multi-pr<strong>of</strong>essional bodies,<br />
GP unions, sickness funds and the Intermutualistic agency (IMA/AMI), INAMI/RIZIV,<br />
organisations <strong>of</strong> patients and s<strong>of</strong>tware suppliers.